Unknown

Dataset Information

JAK inhibitors to treat STAT3 gain-of-function: a single-center report and literature review.


ABSTRACT:

Objective

The signal transducer and activator of transcription 3 (STAT3) gain-of-function (GOF) syndrome (STAT3-GOF) is an inborn error of immunity (IEI) characterized by diverse manifestations of immune dysregulation that necessitate systemic immunomodulatory treatment. The blockade of the interleukin-6 receptor and/or the inhibition of the Janus kinases has been commonly employed to treat diverse STAT3-GOF-associated manifestations. However, evidence on long-term treatment outcome, especially in the case of adult patients, is scarce.

Methods

Clinical data, including laboratory findings and medical imaging, were collected from all seven patients, diagnosed with STAT3-GOF, who have been treated at the Hannover University School, focusing on those who received a Janus kinase

SUBMITTER: Atschekzei F 

PROVIDER: S-EPMC11377292 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature